Patents Assigned to Savine Therapeutics Pty Ltd
  • Patent number: 7820786
    Abstract: Aspects of the present invention are related to a synthetic polypeptide comprising a plurality of different segments from one or more parent polypeptides, linked together in such a way that is different from their linkage in the one or more parent polypeptides, in such way as to impede, abrogate or otherwise alter at least one function associated with the linkage in the one or more parent polypeptides, and in such a way that their product is not similar in function and/or structure to at least a portion of the one or more parent polypeptides. Additional aspects include a synthetic polynucleotide encoding the synthetic polypeptide, methods of production, a synthetic construct and methods of using the synthetic polypeptide, nucleotide construct and compositions comprising the above. Another aspect is directed towards a computer program product for designing these synthetic polypeptides and polynucleotides.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: October 26, 2010
    Assignee: Savine Therapeutics Pty Ltd
    Inventors: Scott Anthony Thomson, Ian Alistair Ramshaw